{"title": "Traditional Chinese medicine, Fuzheng KangAi decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway Corrigendum in /10.3892/mmr.2021.12244", "author": "Li; Longmei; Wang; Sumei; Yang; Xiaobin; Long; Shunqin; Xiao; Shujing; Wu; Wanyin; Hann; Swei Sunny", "url": "https://www.spandidos-publications.com/10.3892/mmr.2017.6905", "hostname": "spandidos-publications.com", "description": "Lung cancer is a leading cause of cancerassociated mortality worldwide, including in developing countries such as China. Traditional Chinese medicine may provide a novel insight for the treatment of patients with lung cancer. The present study aimed to uncover the mechanism by which the Chinese herbal medicine, Fuzheng KangAi (FZKA), functions on lung cancer cell metastasis. The results demonstrated that treatment with FZKA markedly inhibited cell viability, migration and invasion of lung cancer cells, as determined by cell viability and Transwell assays. Notably, the activity and expression of matrix metalloproteinase 9 (MMP9) was significantly inhibited by FZKA treatment on lung cancer cells, as determined by an MMP9 activity assay and western blot analysis. Furthermore, FZKA markedly inhibited epithelialmesenchymal transition (EMT) of lung cancer cells by inhibiting the expression of the mesenchymal markers Ncadherin and vimentin. In addition, activation of the oncoprotein signal transducer and activator of transcription 3 (STAT3) was suppressed following treatment with FZKA. Conversely, overexpression of STAT3 was able to rescue MMP9 activity following FZKA treatment. The present study indicated that FZKA may inhibit lung cancer metastasis via the STAT3/MMP9 pathway and EMT, suggesting that FZKA may serve as a novel promising therapeutic strategy for the treatment of patients with late stage lung cancer.", "sitename": "Molecular Medicine Reports", "date": "2017-09-01", "cleaned_text": "| | 1 [ ] | | [ ]Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J [View Article](http://dx.doi.org/10.3322/caac.21208) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Cancer%20statistics,%202014) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/24399786) | | 2 [ ] | | [ ]Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277-300. 2010. [View Article](http://dx.doi.org/10.3322/caac.20073) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Cancer%20statistics,%202010) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/20610543) | | 3 [ ] | | [ ]Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J: Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 25:10-21. 2013. [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/23372337) | | 4 [ ] | | [ ]Verdecchia A, Francisci S, Brenner H, Gatta I, al: Working Group: Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 Article](http://dx.doi.org/10.1016/S1470-2045(07)70246-2) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=EUROCARE-4%20Working%20Group:%20Recent%20cancer%20survival%20in%20Europe:%20A%202000%E2%80%9302%20period%20analysis%20of%20EUROCARE-4%20data) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/17714993) 5 [ ] | | [ ]Thomas G: Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat Rev Cell Article](http://dx.doi.org/10.1038/nrm934) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Furin%20at%20the%20cutting%20edge:%20From%20protein%20traffic%20to%20embryogenesis%20and%20disease) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/12360192) | 6 [ ] | | [ ]Fidler IJ: The pathogenesis of cancer metastasis: The 'seed and hypothesis revisited. Rev 2003. [View Article](http://dx.doi.org/10.1038/nrc1098) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20cancer%20metastasis:%20The%20%E2%80%98seed%20and%20soil%E2%80%99%20hypothesis%20revisited) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/12778135) | | 7 ]Rhee JS and Coussens LM: RECKing [View Article](http://dx.doi.org/10.1016/S0962-8924(02)02280-8) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=RECKing%20MMP%20function:%20Implications%20for%20cancer%20development) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/12062160) | | 8 [ ] | | [ ]Wang R, Ke ZF, Wang F, Zhang WH, Wang YF, Li SH and Wang LT: GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its : | | 9 ] | | [ ]Ahmad R, Shihab PK, Jasem Scholar](http://scholar.google.com/scholar_lookup?title=FSL-1%20induces%20MMP-9%20production%20through%20TLR-2%20and%20NF-%CE%BAB/AP-1%20signaling%20pathways%20in%20monocytic%20THP-1%20cells) : | 10 [ ] | | [ ]Yang CQ, Li W, Li SQ, Li J, Li YW, Kong SX, Liu RM, Wang SM and Lv MAPK signaling pathways in human aortic : [Google Scholar](http://scholar.google.com/scholar_lookup?title=MCP-1%20stimulates%20MMP-9%20expression%20via%20ERK%201/2%20and%20p38%20MAPK%20signaling%20pathways%20in%20human%20aortic%20smooth%20muscle%20cells) : | | 11 [ ] | | [ ]Cheng X, Yang Y, Fan Z, Yu L, Bai H, Zhou B, Wu X, Xu H, Fang M, Shen A, et al: MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription. Oncogene. 34:5570-5581. 2015. [View Article](http://dx.doi.org/10.1038/onc.2015.14) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=MKL1%20potentiates%20lung%20cancer%20cell%20migration%20and%20invasion%20by%20epigenetically%20activating%20MMP9%20transcription) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/25746000) | | 12 [ ] | | [ ]Sreekumar R, Sayan BS, Mirnezami AH and Sayan | | 13 [ ] | | [ ]Xia H and Hui KM: MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 19:723-730. 2012. [View Article](http://dx.doi.org/10.1038/cgt.2012.58) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=MicroRNAs%20involved%20in%20regulating%20epithelial-mesenchymal%20transition%20and%20cancer%20stem%20cells%20as%20molecular%20targets%20for%20cancer%20therapeutics) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/22975591) 14 ] | | [ ]Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao C and Darnell JE Jr: Stat3 Article](http://dx.doi.org/10.1016/S0092-8674(00)81959-5) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Stat3%20as%20an%20oncogene) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/10458605) | | 15 [ ] | | [ ]Song L, Turkson J, Karras JG, Jove R Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell cells. Oncogene. 22:4150-4165. 2003. [View Article](http://dx.doi.org/10.1038/sj.onc.1206479) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Activation%20of%20Stat3%20by%20receptor%20tyrosine%20kinases%20and%20cytokines%20regulates%20survival%20in%20human%20non-small%20cell%20carcinoma%20cells) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/12833138) | | 16 [ ] | | [ ]Liu F, Zhang T, Zou S, Jiang B and Hua D: B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Mol Med Rep. 12:5455-5460. 2015. [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/26151358) | | 17 [ ] | | [ ]Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, WF, Zhou YS, Liao combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Study protocol for a randomized controlled trial. Trials. 16:1462015. [View Article](http://dx.doi.org/10.1186/s13063-015-0685-2) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Fuzheng%20Kang'ai%20decoction%20combined%20with%20gefitinib%20in%20advanced%20non-small%20cell%20lung%20cancer%20patients%20with%20epidermal%20growth%20factor%20receptor%20mutations:%20Study%20protocol%20for%20a%20randomized%20controlled%20trial) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/25873045) | | [ ] | | [ ]Wu WY, Yang XB, Deng H, Long SQ, Sun LS, He WF, Zhou YS, Liao GY, Chan SM and Shan SP: Treatment of advanced non-small cell lung cancer with extracorporeal high frequency thermotherapy combined with Chinese medicine. Chin J Integr Med. 16:406-410. 2010. [View Article](http://dx.doi.org/10.1007/s11655-010-0535-8) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Treatment%20of%20advanced%20non-small%20cell%20lung%20cancer%20with%20extracorporeal%20high%20frequency%20thermotherapy%20combined%20with%20Chinese%20medicine) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/20872115) | | 19 [ ] | | [ ]Yang XB, Wu WY, Long SQ, Deng H and Pan ZQ: Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: A retrospective case-control study. Article](http://dx.doi.org/10.1016/j.ctim.2014.10.001) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Effect%20of%20gefitinib%20plus%20Chinese%20herbal%20medicine%20(CHM)%20in%20patients%20with%20advanced%20non-small-cell%20lung%20cancer:%20A%20retrospective%20case-control%20study) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/25453521) | | 20 [ ] | | [ ]Zheng F, Wu J, Li X, Tang Q, Yang L, Yang X, Wu W and Hann SS: Chinese Herbal Medicine Fuzheng Kang-Ai Decoction inhibited lung cancer cell growth interplay of Scholar](http://scholar.google.com/scholar_lookup?title=Chinese%20Herbal%20Medicine%20Fuzheng%20Kang-Ai%20Decoction%20inhibited%20lung%20cancer%20cell%20growth%20through%20AMPK%CE%B1-mediated%20induction%20and%20interplay%20of%20IGFBP1%20and%20FOXO3a) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/27057199) | | 21 [ ] | | [ ]Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 101:293-299. 2010. [View Article](http://dx.doi.org/10.1111/j.1349-7006.2009.01419.x) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Epithelial-mesenchymal%20transition%20in%20cancer%20development%20and%20its%20clinical%20significance) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/19961486) | | 22 [ ] | | [ ]Wan L, Pantel K and Kang Y: Tumor metastasis: Moving new biological insights into the clinic. Nat Med. 19:1450-1464. 2013. [View Article](http://dx.doi.org/10.1038/nm.3391) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Tumor%20metastasis:%20Moving%20new%20biological%20insights%20into%20the%20clinic) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/24202397) | 23 ] | | [ ]Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: New insights in signaling, development and disease. J Cell Biol. 172:973-981. 2006. [View Article](http://dx.doi.org/10.1083/jcb.200601018) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=The%20epithelial-mesenchymal%20transition:%20New%20insights%20in%20signaling,%20development%20and%20disease) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/16567498) | | 24 [ ] | | [ ]Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, et al: STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer. 125:1884-1893. 2009. [View Article](http://dx.doi.org/10.1002/ijc.24567) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=STAT3%20activation%20contributes%20directly%20to%20Epstein-Barr%20virus-mediated%20invasiveness%20of%20nasopharyngeal%20cancer%20cells%20in%20vitro) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/19588483) | | 25 [ ] | | [ ]Guo K, Ma Q, Li J, Wang Z, Shan T, Li W, Xu Q and Xie K: Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Scholar](http://scholar.google.com/scholar_lookup?title=Interaction%20of%20the%20sympathetic%20nerve%20with%20pancreatic%20cancer%20cells%20promotes%20perineural%20invasion%20through%20the%20activation%20of%20STAT3%20signaling) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/23288783) 26 [ ] | | [ ]El-Badrawy MK, Yousef AM, Shaalan D and Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, | | 27 [ ] | | [ ]Vilen ST, Salo T, Sorsa T and Nyberg P: Fluctuating roles of [Google Scholar](http://scholar.google.com/scholar_lookup?title=Fluctuating%20roles%20of%20matrix%20metalloproteinase-9%20in%20oral%20squamous%20cell%20carcinoma) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/23365550) | | 28 [ ] | | [ ]Backstrom JR and T\u00f6k\u00e9s ZA: The 84-kDa form of human matrix metalloproteinase-9 degrades P and J Article](http://dx.doi.org/10.1046/j.1471-4159.1995.64031312.x) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=The%2084-kDa%20form%20of%20human%20matrix%20metalloproteinase-9%20degrades%20substance%20P%20and%20gelatin) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/7532211) | | 29 [ ] | | [ ]Yu H and Jove R: The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 4:97-105. 2004. [View Article](http://dx.doi.org/10.1038/nrc1275) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=The%20STATs%20of%20cancer-new%20molecular%20targets%20come%20of%20age) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/14964307) | | 30 [ ] | | [ ]Ao N and Liu Y, Bian X, Feng H and Liu Y: Ubiquitin-specific peptidase 22 inhibits colon cancer cell invasion by suppressing the signal transducer and activator of transcription 3/matrix metalloproteinase 9 pathway. Mol Med Rep. 12:2107-2113. 2015. [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/25902005) | | 31 [ ] | | [ ]Shirakihara T, Saitoh M and Miyazono K: Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/17615296) | | 32 [ ] | | [ ]Gupta GP and Massagu\u00e9 J: Cancer metastasis: Building Article](http://dx.doi.org/10.1016/j.cell.2006.11.001) : [Google Scholar](http://scholar.google.com/scholar_lookup?title=Cancer%20metastasis:%20Building%20a%20framework) : [PubMed/NCBI](http://www.ncbi.nlm.nih.gov/pubmed/17110329) | | 33 [ ] | | [ ]Orlichenko LS and Radisky DC: Matrix metalloproteinases "}